Entrevista de José Alarcón con Alberto de Rosa Torner

Entrevista Alberto de Rosa Torner

El Programa Alzira implementado desde la década de los 90s en Valencia, España, constituye un óptimo ejemplo de cómo la conjunción de la iniciativa privada y pública en salud puede proporcionar óptimos resultados con el objetivo de contar con una población saludable. Alberto de Rosa Torner, CEO Grupo Ribera Salud, detalla los logros del Programa Alzira.

 
Primera CápsulaPrimera Cápsula: Ribera Salud - Programa Alzira
Segunda CápsulaSegunda Cápsula: Ribera Salud - Programa Alzira
Tercera CápsulaTercera Cápsula: Ribera Salud - Programa Alzira
Cuarta CápsulaCuarta Cápsula: Ribera Salud - Programa Alzira
Quinta CápsulaQuinta Cápsula: Ribera Salud - Programa Alzira
Sexta CápsulaSexta Cápsula: Ribera Salud - Programa Alzira
Septima CápsulaSéptima Cápsula: Ribera Salud - Programa Alzira
 

Primera Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Segunda Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Tercera Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Cuarta Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Quinta Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Sexta Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Séptima Cápsula
Alberto de Rosa Torner, CEO Grupo Ribera Salud - Programa Alzira.

Global Healthcare insights

Faster, better, cheaper

Creating opportunities in a converging healthcare industry

Although healthcare challenges can vary from region to region, health systems around the world face a common challenge: how to curb rising costs while meeting a growing demand for quality care. PwC's global reach and qualifications in the healthcare industry deliver business insights and opportunities for payers, providers, new entrants and strategic investors.

Discover how PwC can help you:

  • Realise maximum benefit from Health Information Technology (HIT)
  • Navigate a complex and rapidly evolving regulatory environment
  • Use public-private partnerships to finance health infrastructure and delivery
  • Tap into the potential of personalised medicine

Learn more  

16th Annual CEO Survey

How Healthcare CEOs are creating resilient organisations

Healthcare is going through a period of disruption as the way in which care is financed and delivered changes. However, despite the turmoil, healthcare CEOs are positive about their prospects for growth. The survey results reflect general optimism that healthcare will continue to be a growing industry in 2013 and that faster, better, cheaper solutions to healthcare problems are paramount. Below are some of the key findings:

  • 77% are confident of generating higher revenues in the next 12 months
  • 42% see organic growth in existing domestic markets as their main opportunity for expansion
  • 82% plan to change their strategies for acquiring and retaining patients over the next 12 months
  • Only 24% are somewhat or very concerned about their ability to protect intellectual property and consumer data
  • Healthcare CEOs are more interested than those in other sectors to collaborate. 66% plan to enter into a new strategic alliance or joint venture in 2013

Learn more  

HealthCast

Global Best Practices in Bending the Cost Curve

This publication is the result of an ongoing global symposia series where the top minds in healthcare discuss innovative methods to curtail costs. HealthCast is a compendium of the case studies presented to date through the series along with a preface that distills nine recurring themes and explains how they are relevant to a wide range of businesses across the global healthcare value chain.

This edition of HealthCast, the latest in PwC's flagship series, discusses key themes like integrated care and public-private partnerships and their implications to the healthcare industry. We include 13 video interviews with CEOs and Ministers to supplement the report.

The 20 case studies from 12 countries featured demonstrate that global solutions to local challenges faced by payers, providers, and the pharmaceutical industry alike exist and can be leveraged to drive change and innovation in the industry.

Learn more  

mHealth

How can we be sure that mobile healthcare (mHealth) isn't just technology-driven hype?

In this PwC-commissioned report from the Economist Intelligence Unit (EIU), patients, doctors and payers share their views on mHealth. Find out what they told us, and learn more about the potential of mobile health in developed and emerging markets, the challenges, and the impact on stakeholders. Read more

  Watch video